Cronos Group Inc (CRON)
2.37
-0.03
(-1.25%)
USD |
NASDAQ |
Apr 19, 16:00
2.36
-0.01
(-0.42%)
After-Hours: 16:22
Cronos Group Enterprise Value: 50.14M for April 18, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
April 18, 2024 | 50.14M |
April 17, 2024 | 57.77M |
April 16, 2024 | 65.39M |
April 15, 2024 | 65.39M |
April 12, 2024 | 92.09M |
April 11, 2024 | 103.52M |
April 10, 2024 | 130.22M |
April 09, 2024 | 153.09M |
April 08, 2024 | 164.53M |
April 05, 2024 | 156.91M |
April 04, 2024 | 183.60M |
April 03, 2024 | 233.17M |
April 02, 2024 | 145.47M |
April 01, 2024 | 141.65M |
March 28, 2024 | 130.22M |
March 27, 2024 | 164.53M |
March 26, 2024 | 141.65M |
March 25, 2024 | 84.46M |
March 22, 2024 | 130.22M |
March 21, 2024 | 46.33M |
March 20, 2024 | 34.89M |
March 19, 2024 | 8.200M |
March 18, 2024 | -14.68M |
March 15, 2024 | -64.25M |
March 14, 2024 | -110.00M |
Date | Value |
---|---|
March 13, 2024 | -94.75M |
March 12, 2024 | -113.82M |
March 11, 2024 | -110.00M |
March 08, 2024 | -106.19M |
March 07, 2024 | -113.82M |
March 06, 2024 | -117.63M |
March 05, 2024 | -113.82M |
March 04, 2024 | -129.07M |
March 01, 2024 | -94.75M |
February 29, 2024 | -71.87M |
February 28, 2024 | -3.240M |
February 27, 2024 | 12.01M |
February 26, 2024 | -10.87M |
February 23, 2024 | -14.68M |
February 22, 2024 | -18.49M |
February 21, 2024 | -29.93M |
February 20, 2024 | -22.30M |
February 16, 2024 | 0.5735M |
February 15, 2024 | -26.12M |
February 14, 2024 | -60.43M |
February 13, 2024 | -60.43M |
February 12, 2024 | -37.56M |
February 09, 2024 | -22.30M |
February 08, 2024 | -41.37M |
February 07, 2024 | -49.00M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-203.72M
Minimum
Aug 15 2023
4.309B
Maximum
Feb 10 2021
854.86M
Average
550.69M
Median
Enterprise Value Benchmarks
Tilray Brands Inc | 1.493B |
Clever Leaves Holdings Inc | 1.573M |
Flora Growth Corp | 15.53M |
Acasti Pharma Inc | 3.742M |
Aurinia Pharmaceuticals Inc | 345.12M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -44.79M |
Revenue (Quarterly) | 23.92M |
Total Expenses (Quarterly) | 42.08M |
EPS Diluted (Quarterly) | -0.11 |
Gross Profit Margin (Quarterly) | 8.00% |
Profit Margin (Quarterly) | -187.3% |
Earnings Yield | -7.78% |
Normalized Earnings Yield | -2.064 |